Using a harmless virus, they introduced a gene for a light-sensitive protein into "inner retinal neurons" in a strain of mice with photoreceptor deficiency that resembles the defect in such inherited human disorders as retinitis pigmentosa. Unlike the retinal rods and cones that normally function as light-sensing cells in the eye, these retinal neurons are normally not photosensitive. The light-sensitive protein they used, called channelrhodopsin-2 (ChR2), is found in green algae.
As reported in the April 6, 2006 issue of Neuron, Zhuo-Hua Pan of Wayne State University School of Medicine and colleagues found that the introduced protein rendered the retinal neurons sensitive to light. What’s more, they found, the protein persisted for long periods in the neurons, and the neurons generated signals that were transmitted to the visual cortex of the animals’ brains.
"With this strategy, the investigators have made a paradigm shift in the field and opened the possibility of genetically modifying the surviving retinal interneurons to function as a replacement light-sensing receptor," wrote John Flannery and Kenneth Greenberg in a preview of the paper in the same issue of Neuron. "This publication is clearly a significant first step into this new field of re-engineering retinal interneurons as genetically modified ’prosthetic’ cells," they wrote.
Pan and his colleagues cautioned that far more research must be done to determine whether their genetic engineering approach can be applied to restore vision in humans with inherited retinal degeneration disorders. For one thing, they said, they have not yet determined whether the light signals reaching the visual cortex could be interpreted as vision. Also, the algal protein is less sensitive to light than is the normal light-detecting protein in the eye.
Finally, they wrote, it remains unclear which of the many inherited retinal diseases might be treatable by using the technique. "The remodeling of inner retinal neurons triggered by photoreceptor degeneration has raised some concerns for the retinal-based rescue strategy after the death of photoreceptors," wrote Pan and colleagues. "However, retinal degenerative diseases are heterogeneous as to the time course of the degeneration, survival cell types, and, possibly, their functional state. Therefore, further studies are required to evaluate what types of retinal degenerative diseases and/or what disease stages are suitable for this potential treatment strategy," they wrote.
However, noted the researchers, their technique avoids some problems presented by other approaches to restoring vision in such diseases. These approaches include transplantation of normal photoreceptor cells into the eye or implantation of electronic retinal "chips" to replace the photoreceptor function.
"An important advantage of the strategy sought in this study is that it does not involve the introduction of tissues or devices into the retina and, therefore, may largely avoid the complications of immune reactions and biocompability," wrote the researchers. "In addition, it could potentially achieve high spatial resolution for the restored ’vision’ because the approach targets the cellular level. Thus, the expression of microbial-type channelrhodopsins, such as ChR2, in surviving retinal neurons may be another potential strategy for the treatment of complete blindness caused by rod and cone degeneration," they wrote.
Heidi Hardman | EurekAlert!
Lethal combination: Drug cocktail turns off the juice to cancer cells
12.12.2018 | Universität Basel
Smelling the forest – not the trees
12.12.2018 | Universität Konstanz
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...
What if a sensor sensing a thing could be part of the thing itself? Rice University engineers believe they have a two-dimensional solution to do just that.
Rice engineers led by materials scientists Pulickel Ajayan and Jun Lou have developed a method to make atom-flat sensors that seamlessly integrate with devices...
Scientists at the University of Stuttgart and the Karlsruhe Institute of Technology (KIT) succeed in important further development on the way to quantum Computers.
Quantum computers one day should be able to solve certain computing problems much faster than a classical computer. One of the most promising approaches is...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
12.12.2018 | Health and Medicine
12.12.2018 | Physics and Astronomy
12.12.2018 | Health and Medicine